Has Paul Digiorgi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $665,916 in general payments to Paul Digiorgi, MD across 412 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Digiorgi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Digiorgi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Digiorgi, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Port Charlotte, FLNPI 1801013404

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $511,882 of the $665,916 with a category attached, or 76.9%. Arthrex accounts for 87.9% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $202,695, 8.5 times the $23,862 reported in 2019. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$665,916in general payments, 2019–2025

Across 412 payments — averaging $1616.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$585K
Atricure, Inc.$35K
Edwards Lifesciences$17K
LSI Solutions Inc$10K
Pacira Pharmaceuticals Incorporated$8K
Intuitive Surgical$3K
plus $7K from 28 others

$324,880in research payments, 2019–2025

Across 20 payments — averaging $16,244 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Atricure, Inc.$204K
Arthrex$121K

What the payments were for

Royalty or licence$511,88277%
Consulting fees$101,71115%
Speaking & faculty fees$15,2002%
Travel & lodging$20,7993%
Food & beverage$16,3242%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	132	$585,042
Atricure, Inc.	72	$35,363
Edwards Lifesciences	72	$17,188
LSI Solutions Inc	4	$10,338
Pacira Pharmaceuticals Incorporated	8	$8,085
Intuitive Surgical	17	$2,502
Medtronic(2 entities)	45	$2,330
Haemonetics Corporation	3	$1,596
Abbott	6	$474
Abiomed	5	$352
Coastal Medical Technologies LLC	4	$349
CGG Medical Inc	6	$334
Johnson & Johnson	4	$274
Getinge USA Sales, LLC	6	$225
AstraZeneca	2	$223
La Jolla Pharmaceutical Company	3	$160
W. L. Gore & Associates, Inc.	1	$159
Solventum Corporation	2	$158
Livanova USA, Inc.	1	$120
Kls-martin L.p.	1	$89
Corcym Inc	1	$84
Irhythm Technologies, Inc.	1	$68
BD	1	$50
Cvrx, Inc.	2	$50
Zimmer Biomet	2	$47
Cardiva Medical, Inc.	2	$42
Pfizer	1	$40
Bard Access Systems, Inc.	2	$38
Nuwellis, Inc.	1	$29
MVP Orthopedics Inc	1	$28
Angiodynamics, Inc.	1	$24
Mallinckrodt Enterprises LLC	1	$22
Stryker	1	$17
Philips North America LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$2,475,192
AR-7289$34,713
AR-7289T$30,368
SYNERGY ABLATION SYSTEM$17,514
RAM$10,314
COR KNOT$9,203
EXPAREL$7,917
ISOLATOR SURGICAL ABLATION SYSTEM$2,438
Da Vinci Surgical System$2,141
ATRICLIP LAA EXCLUSION SYSTEM$2,128
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,668
TEG6s HEMOSTASIS SYSTEM$1,500
OTHER SUTURE SHOULDER CERCLAGE$1,200
ATRICURE ATRICLIP LAA EXCLUSION$963
COREVALVE EVOLUT R$931
MITRIS RESILIA Mitral Valve$787
SHOULDER IMPLANTS OTHER OTHER$600
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$532
SEW-EASY$506
miniRUMEL$506

How this compares

$665,916 in reported general payments places this provider in the 95th percentile of 408 thoracic surgery (cardiothoracic vascular surgery) providers in Florida.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Florida →

Medicare billing

Part B allowed, 2024

$248,897

Medicare patients

187

Services billed

467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Port Charlotte

Anthony NunezOrlando$4.8M
Barry WintonLargo$687K
John PirrisJacksonville$640K
Jacques FontaineTampa$630K
Andrew ShermanTampa$517K
Rogerio CarrilloHialeah$515K
Daniel O'HairFort Myers$429K
Luis HerreraOrlando$409K
Joseph LamelasMiami$379K
Lucian LozonschiTampa$354K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →